Medicines and Poisons (Medicines) Amendment Regulation (No. 4) 2025 (Qld)
1 Short title
This regulation may be cited as the Medicines and Poisons (Medicines) Amendment Regulation (No. 4) 2025.
2 Commencement
This regulation commences on 1 December 2025.
3 Regulation amended
This regulation amends the Medicines and Poisons (Medicines) Regulation 2021.
4 Amendment of s 86 (Content of written prescription)
Section 86(1)(m)—
omit, insert—(m)if the medicine is a restricted medicine—the details of the prescriber’s authorisation to prescribe the restricted medicine.Examples for paragraph (m)—
•the identifying number of the prescribing approval held by the prescriber•the qualifications of the prescriber
5 Amendment of s 87 (Additional content of written prescription for S8 medicine)
(1)Section 87(2)(c)—
omit, insert—(c)if the S8 medicine is a psychostimulant medicine—(i)words to indicate the condition being treated; or(ii)the words ‘specified condition’ if the medicine is for the treatment of a specified condition.(2)Section 87—
insert—(7)In this section—specified condition means—(a)ADHD; or(b)brain injury; or(c)narcolepsy.
6 Amendment of s 161 (Selling S3 medicine with instructions for use)
Section 161(3), example, ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
7 Amendment of s 234 (Unlawful advertising of medicines)
Section 234(2)(a)(ii)—
omit, insert—(ii)in accordance with the Therapeutic Goods Advertising Code under the Therapeutic Goods Act 1989 (Cwlth); or
8 Amendment of sch 1 (Extended practice authorities and departmental standards)
Schedule 1, part 1, table—
omit, insert—
Name
Version
Aboriginal and Torres Strait Islander health practitioners
6
Aboriginal and Torres Strait Islander health workers
4
Indigenous health workers
5
Queensland Ambulance Service
5
Midwives
5
Registered nurses
6
Pharmacists
9
Pharmacists—community pharmacy chronic conditions management pilot
1
Physiotherapists
3
9 Amendment of sch 2 (Categories of medicines)
(1)Schedule 2, part 1, division 1, entry for hydroxychloroquine—
omit.(2)Schedule 2, part 1, division 2, entries for amfetamines and methylphenidate—
omit.(3)Schedule 2, part 1, division 2—
insert—all psychostimulant medicines
10 Omission of sch 4, pt 1, div 3 (Specialist dentists)
Schedule 4, part 1, division 3—
omit.
11 Amendment of sch 4, pt 2 (Dental hygienists)
Schedule 4, section 9, table, item 1, column 2, paragraph (a), first dot point—
omit, insert—•an adrenaline (epinephrine) device;
12 Amendment of sch 4, pt 3 (Dental therapists)
Schedule 4, section 11, table, item 1, column 2, paragraph (a), first dot point—
omit, insert—•an adrenaline (epinephrine) device;
13 Amendment of sch 4, pt 4 (Oral health therapists)
Schedule 4, section 13, table, item 1, column 2, paragraph (a), first dot point—
omit, insert—•an adrenaline (epinephrine) device;
14 Amendment of sch 5, pt 2 (First aid providers)
Schedule 5, section 6, table, item 1, column 2, paragraph (b), ‘adrenaline (epinephrine) autoinjector’—
omit, insert—an adrenaline (epinephrine) device
15 Omission of sch 6, pt 1, div 4 (Continuing treatment with hydroxychloroquine)
Schedule 6, part 1, division 4—
omit.
16 Replacement of sch 6, pt 1, div 5 (Dealing with amfetamines or methylphenidates)
Schedule 6, part 1, division 5—
omit, insert—Division 5 Dealing with psychostimulant medicines
11 Definition for division
In this division—relevant condition means—(a)narcolepsy; or(b)ADHD, or brain injury, of a child patient who is 4 years or more.12 Class of person
A medical practitioner.13 Dealing authorised
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
a psychostimulant medicine
the medicine is prescribed for the treatment of a relevant condition
2
give a treatment dose
a psychostimulant medicine
the medicine is given for the treatment of a relevant condition
3
dispense
a psychostimulant medicine
the medicine is dispensed for the treatment of a relevant condition
4
administer
a psychostimulant medicine
the medicine is administered for the treatment of a relevant condition
5
give a purchase order
stock of a psychostimulant medicine
the stock is for the treatment of relevant conditions, other than at a specified place
6
possess
a psychostimulant medicine
the medicine is possessed for a purpose mentioned in this column
17 Amendment of sch 6, pt 2, hdg (Specialist medical practitioners)
Schedule 6, part 2, heading, after ‘practitioners’—
insert—and registrars
18 Amendment of sch 6, pt 2, div 3 (Dermatologists)
Schedule 6, section 22, ‘hydroxychloroquine,’—
omit.
19 Omission of sch 6, pt 2, div 4 (Emergency medicine physicians)
Schedule 6, part 2, division 4—
omit.
20 Insertion of new sch 6, pt 2, div 5A
Schedule 6, part 2—
insert—Division 5A General practitioners
26A Definition for division
In this division—adult ADHD means ADHD of an adult patient.26B Class of person
A medical practitioner who is a specialist registrant in general practice.26C Dealing authorised
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
a psychostimulant medicine
the medicine is prescribed for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine
2
give a treatment dose
a psychostimulant medicine
the medicine is given for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine
3
dispense
a psychostimulant medicine
the medicine is dispensed for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine
4
administer
a psychostimulant medicine
the medicine is administered for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine
5
give a purchase order
stock of a psychostimulant medicine
the stock is for the treatment of adult ADHD, other than at a specified place
6
possess
a psychostimulant medicine
the medicine is possessed for a purpose mentioned in this column
21 Amendment of sch 6, pt 2, div 8 (Haematologists)
Schedule 6, section 32, ‘hydroxychloroquine,’—
omit.
22 Omission of sch 6, pt 2, div 9 (Immunologists)
Schedule 6, part 2, division 9—
omit.
23 Amendment of sch 6, pt 2, div 10 (Infectious diseases specialists)
Schedule 6, section 36, ‘hydroxychloroquine or’—
omit.
24 Omission of sch 6, pt 2, div 11 (Intensive care physicians)
Schedule 6, part 2, division 11—
omit.
25 Omission of sch 6, pt 2, div 13 (Nephrologists)
Schedule 6, part 2, division 13—
omit.
26 Amendment of sch 6, pt 2, div 15 (Paediatricians)
(1)Schedule 6, section 45—
omit, insert—45 Definitions for division
In this division—relevant child condition means ADHD, or brain injury, of a child patient.young adult ADHD means ADHD of an adult patient who is under 25 years.(2)Schedule 6, section 47—
omit, insert—47 Dealing authorised
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
the medicine is prescribed—
• for the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition2
give a treatment dose
the medicine is given—
• for the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition3
dispense
the medicine is dispensed—
• for the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition4
administer
the medicine is administered—
• for the treatment of young adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition5
give a purchase order
the stock is for the treatment of young adult ADHD or relevant child conditions, other than at a specified place
the stock is not for a specified place
6
possess
the medicine is possessed for a purpose mentioned in this column
27 Amendment of sch 6, pt 2, div 16 (Psychiatrists)
(1)Schedule 6, section 48, definitions maximum dosage, relevant adult condition and relevant child condition—
omit.(2)Schedule 6, section 48—
insert—adult ADHD means ADHD of an adult patient.relevant child condition means ADHD, or brain injury, of a child patient.(3)Schedule 6, section 50—
omit, insert—50 Dealing authorised
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
the medicine is prescribed—
• for the treatment of adult ADHD up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition2
give a treatment dose
the medicine is given—
• for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition3
dispense
the medicine is dispensed—
• for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• the treatment of a relevant child condition4
administer
the medicine is administered—
• for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or• for the treatment of a relevant child condition5
give a purchase order
the stock is not for a specified place
the stock is for the treatment of adult ADHD or relevant child conditions, other than at a specified place
6
possess
the medicine is possessed for a purpose mentioned in this column
28 Amendment of sch 6, pt 2, div 18 (Rheumatologists)
Schedule 6, section 54, ‘hydroxychloroquine,’—
omit.
29 Amendment of sch 6, pt 2, div 20 (Specialist physicians)
Schedule 6, section 58, ‘hydroxychloroquine,’—
omit.
30 Amendment of sch 7, pt 1 (Nurse practitioners)
(1)Schedule 7, section 1, definition continuing hydroxychloroquine treatment—
omit.(2)Schedule 7, section 3, table—
omit, insert—
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
prescribe
the medicine is prescribed for administration by a health practitioner—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to prescribe the medicinethe medicine is prescribed for administration for the continuing opioid dependence treatment of a patient
2
make a standing order, other than a clinical protocol
an S2, S3 or S4 medicine, other than an S4 diversion-risk medicine or restricted medicine
3
give a treatment dose
the medicine is given—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to give the medicine4
administer
the medicine is administered—
• for the continuing institutional treatment of a patient; and• under the supervision of a registrar or specialist medical practitioner authorised to give the medicinethe medicine is administered for the continuing opioid dependence treatment of a patient
the medicine is administered on a prescription
5
repackage
any medicine
the medicine is repackaged for giving a treatment dose for a patient
6
give a purchase order
stock of an S4 or S8 medicine
the stock is not for a specified place
7
possess
an S4 or S8 medicine mentioned in this column
the medicine is possessed for a purpose mentioned in this column
8
dispose
waste from a diversion-risk medicine mentioned in this column
31 Amendment of sch 7, pt 3, div 5 (Custodial nurses)
Schedule 7, part 3, section 17, item 1, column 2, ‘amfetamine or methylphenidate’—
omit, insert—a psychostimulant medicine
32 Insertion of new sch 7, pt 3, div 6
Schedule 7, part 3—
insert—Division 6 Hospital and health service nurses
17A Class of person
A registered nurse employed by, or for, a Hospital and Health Service.17B Dealing authorised
Column 1
Dealing
Column 2
Medicine
Column 3
Scope of dealing
1
give a treatment dose
an S2, S3 or S4 medicine, other than a restricted medicine
the medicine is given—
• for preparation of the bowel for a procedure; and• on a prescription or a standing order2
possess
an S4 medicine
the medicine is possessed for a purpose mentioned in this column
33 Amendment of sch 10, pt 2 (Podiatrists)
Schedule 10, section 3, table, item 1, column 2, paragraph (b), ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
34 Amendment of sch 12, pt 2 (Clinical perfusionists)
Schedule 12, section 3(a), ‘at’—
omit, insert—for
35 Amendment of sch 12, pt 3 (Nuclear medicine technologists)
Schedule 12, section 6, table, item 1, column 2, ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
36 Amendment of sch 12, pt 4 (Physiotherapists)
Schedule 12, section 8, table, item 3, column 2, after ‘S4’—
insert—or S8
37 Amendment of sch 12, pt 5 (Respiratory scientists)
(1)Schedule 12, section 9(a), ‘at’—
omit, insert—for
(2)Schedule 12, section 10, table, item 1, column 2, ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
38 Amendment of sch 12, pt 6 (Speech pathologists)
(1)Schedule 12, section 12(a), ‘at’—
omit, insert—for
(2)Schedule 12, section 13, table, item 1, column 2, ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
39 Amendment of sch 13, pt 2 (School workers)
Schedule 13, section 11, table, item 1, column 2, paragraph (a), ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
40 Amendment of sch 13, pt 3 (Child care facilities)
(1)Schedule 13, part 3, heading, ‘facilities’—
omit, insert—workers
(2)Schedule 13, section 16, table, item 1, column 2, paragraph (a), ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
41 Amendment of sch 22 (Dictionary)
(1)Schedule 22, definition adrenaline (epinephrine) autoinjector—
omit.(2)Schedule 22—
insert—ADHD means attention deficit hyperactivity disorder.adrenaline (epinephrine) device means an S3 medicine that is adrenaline (epinephrine) in a device designed to administer a single dose of the medicine for the purpose of managing anaphylaxis or allergic reactions.maximum daily dose, of a psychostimulant medicine, means—(a)for dexamfetamine—40mg a day; or(b)for lisdexamfetamine—70mg a day; or(c)for methylphenidate—80mg a day.psychostimulant medicine means an S8 medicine that is—(a)dexamfetamine, lisdexamfetamine or another type of amfetamine; or(b)methylphenidate.specialist medical practitioner means a medical practitioner who is a specialist registrant in any field of practice.(3)Schedule 22, definition anaphylaxis training, paragraph (b), ‘adrenaline (epinephrine) autoinjector’—
omit, insert—adrenaline (epinephrine) device
0
0
0